Oral Ulcer Drug Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030
Report ID: RC91942 | Report Format: PDF + Excel | Last Updated: August 30th, 2025The global oral ulcer drug market size was valued at over USD 1.5 million in 2024 and projected to grow at a significant CAGR of around 4% during the forecast period 2025 to 2030. The increasing prevalence of oral infection is a major factor to drive the market growth. The increasing consumer shifts toward unhealthy lifestyle such as consuming tobacco, betel nuts, and other junk foods are some other factors to drive the market. The oral ulcer occurs due to poor oral hygiene, accidental biting inside the chick, and eating hot food. Moreover, the rising awareness about oral ulcers and increasing cases in the geriatric population are expected to fuel the market over the forecast period.
Report Attributes:
| Benchmark Year | 2024 | ||
| Market Size | > USD 1.5 Billion in 2024 | ||
| Market Growth (CAGR) | ~ 4% (2025-2030) | ||
| Largest Market Share | lock | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Blistex, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline, Plc, Reckitt Benckiser and 3M Company |
Oral Ulcer Drug Market Driving Factors:
The oral ulcer drug market is primarily driven by the rising prevalence of oral ulcers caused by factors such as stress, nutritional deficiencies, hormonal changes, gastrointestinal disorders, and side effects of certain medications. The growing incidence of oral mucositis among cancer patients undergoing chemotherapy and radiotherapy is another key driver, as these patients often experience painful ulcers that require effective treatment. Additionally, the rising awareness of oral health and the increasing adoption of fast-acting pain-relief and healing products are fueling demand for both over-the-counter (OTC) and prescription oral ulcer drugs.
Another major driving factor is the expansion of geriatric populations worldwide, who are more prone to oral health issues, including recurrent ulcers. Furthermore, the rising consumption of tobacco, alcohol, and spicy foods contributes to higher cases of oral lesions, creating sustained demand for effective therapeutic solutions. The market is also benefiting from advancements in drug formulations, such as mucoadhesive gels, sprays, and lozenges that provide longer-lasting relief, thereby enhancing patient compliance. Together, these factors are supporting the steady growth of the oral ulcer drug market globally.
Industry Trends Shaping the Oral Ulcer Drug Market:
One of the key trends in the oral ulcer drug market is the increasing shift toward OTC and self-care treatments. With a growing number of patients experiencing recurrent minor ulcers, consumers are seeking fast, affordable, and easily accessible solutions without the need for a prescription. This has led to the rising popularity of gels, mouthwashes, sprays, and lozenges that provide immediate pain relief and promote healing. E-commerce platforms are also playing a significant role, enabling wider access to oral ulcer medications and driving competition among brands to offer user-friendly formulations.
Another notable trend is the focus on natural and herbal-based therapies as consumers become more conscious about chemical ingredients and potential side effects. Plant-based extracts with anti-inflammatory, antimicrobial, and wound-healing properties are increasingly being incorporated into oral ulcer products. At the same time, pharmaceutical companies are investing in advanced drug delivery systems, such as bioadhesive films and sustained-release formulations, to enhance treatment effectiveness and patient compliance. These innovations, combined with the emphasis on holistic oral care, are reshaping the dynamics of the oral ulcer drug market.
Oral Ulcer Drug Market Opportunities:
The oral ulcer drug market presents significant opportunities through the development of targeted therapies and advanced formulations that offer faster healing and prolonged relief. Innovations such as bioadhesive films, nanoparticles, and sustained-release drug delivery systems can address the limitations of conventional gels and mouthwashes, improving patient compliance and outcomes. Moreover, the high prevalence of oral mucositis in cancer patients provides opportunities for pharmaceutical companies to expand into specialized segments, where there is strong demand for effective pain management and healing therapies.
Another major opportunity lies in the growing demand for natural, herbal, and OTC products, especially in emerging markets where access to prescription drugs may be limited. Companies that can leverage plant-based ingredients, such as aloe vera, licorice, or chamomile, while ensuring clinical validation, can capture the attention of health-conscious consumers. Additionally, the rapid expansion of online pharmacies and e-commerce channels provides a platform for greater market penetration and brand visibility. With rising awareness of oral health and the willingness of consumers to invest in preventive and therapeutic solutions, the oral ulcer drug market is well-positioned for strong growth.
Market Segments Insights:
The global oral ulcer drug market is bifurcated into drug class, formulation, and geography. On the basis of drug class, the market is further segmented into antihistamine, antimicrobial, analgesic, corticosteroids, and others. The analgesic segment held the largest market share by revenue. The segment growth is attributed to the increasing cases of apthous ulcers in individuals which has increased the demand for analgesics. Furthermore, the corticosteroids segment is expected to grow at a significant growth rate over the forecast period due to its anti-inflammatory properties to treat canker sores.
By formulation, the oral ulcer drug market is fragmented into sprays, mouthwash, gels, and lozenges. The gel segment dominated the market due to fast healing, easy availability, and anti-inflammatory properties. Furthermore, it also available in different flavors and forms which are suitable for both adults and children.
The market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.
Oral Ulcer Drug Market Segmentation:
By Drug Class:
- Antihistamine
- Antimicrobial
- Analgesic
- Corticosteroid
- Others
By Formulation:
- Sprays
- Mouthwash
- Gels
- Lozenges
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage:
Geographically, the oral ulcer drug market report comprises dedicated sections centering on the regional market revenue and trends. The market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years along with forecasts for the period from 2025 – 2030.
Oral Ulcer Drug Market Competition Assessment:
Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy. Key players operating in the global market are Blistex, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline, Plc, Reckitt Benckiser and 3M Company.
Key Companies:
- Blistex, Inc.
- Bristol-Myers Squibb Company.
- GlaxoSmithKline, Plc
- Reckitt Benckiser.
- 3M Company
- Church & Dwight Co, Inc.
- ECR Pharmaceuticals
- Colgate-Palmolive Company
- Sinclair Pharma
- Pfizer, Inc.
Key Questions Answered by Oral Ulcer Drug Market Report:
- Global oral ulcer drug market forecasts from 2021-2027
- Regional market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
- Oral ulcer drug submarket forecasts from 2021-2027 covering the market by type, by function, by end-use, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
- Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2021-2027
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Oral Ulcer Drug Market Portraiture
2.2. Global Oral Ulcer Drug Market, by Drug Class, 2020 (USD Mn)
2.3. Global Oral Ulcer Drug Market, by Formulation, 2020 (USD Mn)
2.4. Global Oral Ulcer Drug Market, by Geography, 2020 (USD Mn)
3. Global Oral Ulcer Drug Market Analysis
3.1. Oral Ulcer Drug Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
4. Global Oral Ulcer Drug Market By Drug Class, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Antihistamine
4.3. Antimicrobial
4.4. Analgesic
4.5. Corticosteroid
4.6. Others
5. Global Oral Ulcer Drug Market By Formulation, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Sprays
5.3. Mouthwash
5.4. Gels
5.5. Lozenges
6. North America Oral Ulcer Drug Market Analysis and Forecast, 2018 – 2027 (USD Mn)
6.1.1. Overview
6.1.2. North America Oral Ulcer Drug Market by Drug Class (2018-2027 USD Mn)
6.1.3. North America Oral Ulcer Drug Market by Formulation (2018-2027 USD Mn)
6.1.4. North America Oral Ulcer Drug Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada
7. Europe Oral Ulcer Drug Market Analysis and Forecast, 2018 – 2027 (USD Mn)
7.1.1. Overview
7.1.2. Europe Oral Ulcer Drug Market by Drug Class (2018-2027 USD Mn)
7.1.3. Europe Oral Ulcer Drug Market by Formulation (2018-2027 USD Mn)
7.1.4. Europe Oral Ulcer Drug Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe
8. Asia Pacific Oral Ulcer Drug Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. Asia Pacific Oral Ulcer Drug Market by Drug Class (2018-2027 USD Mn)
8.1.3. Asia Pacific Oral Ulcer Drug Market by Formulation (2018-2027 USD Mn)
8.1.4. Asia Pacific Oral Ulcer Drug Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific
9. Latin America (LATAM) Oral Ulcer Drug Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Latin America Oral Ulcer Drug Market by Drug Class (2018-2027 USD Mn)
9.1.3. Latin America Oral Ulcer Drug Market by Formulation (2018-2027 USD Mn)
9.1.4. Latin America Oral Ulcer Drug Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America
10. Middle East and Africa Oral Ulcer Drug Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. MEA Oral Ulcer Drug Market by Drug Class (2018-2027 USD Mn)
10.1.3. MEA Oral Ulcer Drug Market by Formulation (2018-2027 USD Mn)
10.1.4. Middle East and Africa Oral Ulcer Drug Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA
11. Company Profiles
11.1. Blistex, Inc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Bristol-Myers Squibb Company
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. GlaxoSmithKline, Plc
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Reckitt Benckiser
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. 3M Company
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Church & Dwight Co, Inc.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. ECR Pharmaceuticals
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Colgate-Palmolive Company
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Sinclair Pharma
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Pfizer, Inc.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
To know more about the study, request a report sample
List of Tables:
TABLE 1 Market Snapshot: Global Oral Ulcer Drug Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Challenges
TABLE 4 Global Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 5 Global Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 6 North America Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 7 North America Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 8 North America Oral Ulcer Drug Market Value, By Country, 2018 - 2027 (US$ Mn)
TABLE 9 U.S. Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 10 U.S. Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 11 Canada Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 12 Canada Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 13 Europe Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 14 Europe Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 15 Europe Oral Ulcer Drug Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 16 Germany Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 17 Germany Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 18 U.K. Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 19 U.K. Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 20 France Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 21 France Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 22 Italy Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 23 Italy Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 24 Rest of Europe Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 25 Rest of Europe Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 26 Asia Pacific Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 27 Asia Pacific Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 28 Asia Pacific Oral Ulcer Drug Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 29 Japan Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 30 Japan Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 31 China Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 32 China Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 33 Rest of Asia Pacific Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 34 Rest of Asia Pacific Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 35 Latin America Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 36 Latin America Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 37 Latin America Oral Ulcer Drug Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 38 Brazil Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 39 Brazil Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 40 Mexico Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 41 Mexico Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 42 Rest of Latin America Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 43 Rest of Latin America Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 44 Middle East & Africa Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 45 Middle East & Africa Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 46 Middle East & Africa Oral Ulcer Drug Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 47 GCC Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 48 GCC Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 49 Rest of MEA Oral Ulcer Drug Market Value, by Drug Class, 2018 - 2027 (US$ Mn)
TABLE 50 Rest of MEA Oral Ulcer Drug Market Value, by Formulation, 2018 - 2027 (US$ Mn)
TABLE 51 Blistex, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 52 Bristol-Myers Squibb Company.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 53 GlaxoSmithKline, Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 54 Reckitt Benckiser: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 55 3M Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 56 Church & Dwight Co, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 57 ECR Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 58 Colgate-Palmolive Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 59 Sinclair Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 60 Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
To know more about the study, request a report sample
List of Figures:
FIG. 1 Global Oral Ulcer Drug: Market Segmentation
FIG. 2 Global Oral Ulcer Drug Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Oral Ulcer Drug Market, by Drug Class, 2019 (US$ Mn)
FIG. 5 Global Oral Ulcer Drug Market, by Formulation, 2019 (US$ Mn)
FIG. 6 Global Oral Ulcer Drug Market, by Geography, 2019 (US$ Mn)
FIG. 7 Global Oral Ulcer Drug Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Market Positioning of Key Oral Ulcer Drug Providers, 2019
FIG. 10 Global Oral Ulcer Drug Market Value Share, by Drug Class, 2018 & 2027 (%)
FIG. 11 Global Oral Ulcer Drug Market Value for Antihistamine, 2018 - 2027, (US$ Mn)
FIG. 12 Global Oral Ulcer Drug Market Value for Antimicrobial, 2018 - 2027, (US$ Mn)
FIG. 13 Global Oral Ulcer Drug Market Value for Analgesic, 2018 - 2027, (US$ Mn)
FIG. 14 Global Oral Ulcer Drug Market Value for Corticosteroid, 2018 - 2027, (US$ Mn)
FIG. 15 Global Oral Ulcer Drug Market Value for Others, 2018 - 2027, (US$ Mn)
FIG. 16 Global Oral Ulcer Drug Market Value Share, by Formulation, 2018 & 2027 (Value %)
FIG. 17 Global Oral Ulcer Drug Market Value for Sprays, 2018 - 2027, (US$ Mn)
FIG. 18 Global Oral Ulcer Drug Market Value for Mouthwash, 2018 - 2027, (US$ Mn)
FIG. 19 Global Oral Ulcer Drug Market Value for Gels, 2018 - 2027, (US$ Mn)
FIG. 20 Global Oral Ulcer Drug Market Value for Lozenges, 2018 - 2027, (US$ Mn)
FIG. 21 North America Oral Ulcer Drug Market Value, 2018 - 2027, (US$ Mn)
FIG. 22 Europe Oral Ulcer Drug Market Value, 2018 - 2027, (US$ Mn)
FIG. 23 Asia Pacific Oral Ulcer Drug Market Value, 2018 - 2027, (US$ Mn)
FIG. 24 LATIN America Oral Ulcer Drug Market Value, 2018 - 2027, (US$ Mn)
FIG. 25 Middle East & Africa Oral Ulcer Drug Market Value, 2018 - 2027, (US$ Mn)
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers
Our Clients
